Executive Summary
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis Global Blood Plasma Market. The report analyses the Blood Plasma Market By Type (Immunoglobulins- IV+SC, Albumin, Factor VIII- Plasma Derived, and Others), By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S, Canada, Germany, France, Italy, China, Japan, India, Australia, and South-East Asia). The report on Blood Plasma assesses the market for the actual period of 2013-2017 and the forecast period of 2018-2023.
According to Analytics research report “Global Blood Plasma Market – Analysis By Type (Immunoglobulins – IV+SC, Albumin, Factor VIII – Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)”, the global blood plasma market is projected to display a robust growth represented by a CAGR of 10.18% during 2018 – 2023.
The Blood Plasma market witness a substantial growth at a noteworthy rate over the past few years and anticipated to grow on the back of its increasing usage in plasma-derived medical products. In addition, rise in awareness towards plasma donation, rise of China blood plasma industry, introduction of new and specialized products, rising geriatric population, rapid increase of the healthcare expenditure on the diseases such as immunodeficiency, neurological disorders, clotting disabilities etc. anticipated to boost the market growth in future. Amongst the regions, North America accounts for the largest regional share in the global blood plasma market. Key factor driving the robust growth rate in North America region is collection of source plasma in large volume for the fractionation process.
The report titled “Global Blood Plasma Market – Analysis By Type (Immunoglobulins – IV+SC, Albumin, Factor VIII – Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)” has covered and analysed the potential of Global Blood Plasma Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global blood ingredients market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Request Sample Report @ https://www.wiseguyreports.com/sample-request/3501441-global-blood-plasma-market-analysis-by-type-immunoglobulins
Scope of the Report
Global Blood Plasma Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Blood Plasma Market – Size, Growth, Forecast
• Analysis By Type- Size, Volume, Growth, Forecast
o Immunoglobulin (IV+SC)
o Albumin
o Factor VIII (Plasma Derived)
Regional Markets – North America, Europe, Asia Pacific, and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Blood Plasma Market – Size, Growth, Forecast
• Analysis By Type
o Immunoglobulin (IV+SC)
o Albumin
o Factor VIII (Plasma Derived)
Country Analysis – U.S., Canada, Germany, France, Italy, China, Japan, India, Australia, and South-East Asia. (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Blood Plasma Market – Size, Growth, Forecast
• Analysis By Type
o Immunoglobulin (IV+SC)
o Albumin
o Factor VIII (Plasma Derived)
Other Report Highlights
• Market Dynamics – Drivers and Restraints
• Market Trends
• Porter Five Forces Analysis
• Company Analysis – CSL Limited, Baxter International, Grifols S.A, Octa Pharma, Emergent Bio-solutions, Antaris Pharma, AMAG Pharma, Biota Pharma, Bio delivery Science International, Biotest A.G.
Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
Table of Contents
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Global Blood Plasma Market: Product Outlook
5. Global Blood Plasma Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
5.3 By Company Share (2017)
6. Global Blood Plasma Market Size, By Type: Breakdown (%)
6.1 Global Immunoglobulins (IV+SC) Market
6.1.1 By Value (2013-2023)
6.1.2 By Volume (2013-2023)
6.1.3 By Company Share, 2017
6.2 Global Albumin Market
6.2.1By Value (2013-2023)
6.2.2 By Volume (2013-2023)
6.2.3 By Company Share, 2017
6.3 Global FVIII (pd) Market
6.3.1 By Value (2013-2023)
6.3.2 By Volume (2013-2023)
6.3.3 By Company Share, 2017
6.4 Global Other Plasma Product Market: By Value (2013-2023)
6.5 Global Blood Plasma Market: Market Comparison, By Segments
6.6 Global Blood Plasma Market: Market Attractiveness, By Segments
7. Global Blood Plasma Market: Regional Analysis
8. Global Blood Plasma Market Dynamics
8.1 Drivers
8.2 Challenges
8.3 Trends
9. Blood Plasma Market: Policy and Regulatory Landscape
10. Global Blood Plasma Market: Supply Chain Analysis
11. Porter’s Five Forces Analysis
12 Company Profiles
12.1 CSL Limited
12.2 Baxter International
12.3 Grifols S.A.
12.4 Octa Pharma
12.5 Emergent Bio-solutions
12.6 Antaris Pharma
12.7 AMAG Pharma
12.8 Kedrion Biota Pharma
12.9 Bio delivery Science International
12.10 Biotest A.G.
Continuous…
For further information on this report, visit – https://www.wiseguyreports.com/reports/3501441-global-blood-plasma-market-analysis-by-type-immunoglobulins
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com